Results
1
1 companies
argenx
Market Cap: €43.6b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€701.00
7D
1.1%
1Y
36.2%